2002 Step1
2002 Step1
2002 Step1
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Preparing for the Test, Applying for the Test,
Scheduling Test Dates, and Testing . . . . . . . . . . . . . . . . . . . . 3
Examination Content . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Step 1 Test Question Format . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Content Outline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Sample Step 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Normal Laboratory Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
Answer Form for Sample Step 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Test Questions for Sample Step 1 . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Answer Key for Sample Step 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
Introduction Please note that values shown in the actual
examination may differ slightly from those printed in
This booklet is intended to help you prepare for Step 1 this booklet. Other computer interface features include
of the United States Medical Licensing Examination™ clickable icons for marking questions to be reviewed,
(USMLE™) if you are an applicant with an eligibility automated review of marked and incomplete questions,
period that has an ending date in 2003. Eligibility a clock indicating the time remaining, and a help
periods are explained on page 12 of the 2003 application. This will provide examinees with a realistic
USMLE Bulletin of Information, with which you understanding of the computer interface and timing of
must become familiar to apply for the examination. In the examination.
addition to reading the Bulletin, you should run the
sample Step 1 test materials and tutorials provided at
the USMLE website or by your registration entity on Examination Content
CD.
The purpose of Step 1 is to determine if an examinee
The information in this booklet, USMLE sample test understands and can apply important concepts of the
materials and software tutorials, and other sciences basic to the practice of medicine, with a
informational materials are available at the USMLE special emphasis on principles and mechanisms
website (http://www.usmle.org). Information regarding underlying health, disease, and modes of therapy. The
any changes in the USMLE program will also be inclusion of Step 1 in the USMLE sequence is intended
posted at the USMLE website. You must obtain the to ensure mastery of not only the sciences
most recent information to ensure an accurate undergirding the safe and competent practice of
understanding of current USMLE rules. medicine in the present, but also the scientific
principles required for maintenance of competence
through lifelong learning.
Preparing for the Test, Applying for the Test,
Scheduling Test Dates, and Testing Step 1 consists of multiple-choice questions prepared
by examination committees composed of faculty
In addition to the information in this booklet, you should members, teachers, investigators, and clinicians with
review the sections that appear on pages 9-19 in the recognized prominence in their respective fields.
Bulletin: Preparing for the Test, Applying for the Test Committee members are selected to provide broad
and Scheduling Your Test Date, and Testing. representation from the academic, practice, and
licensing communities across the United States and
Although the sample test materials in this booklet are Canada. The test is designed to measure basic science
the same as those provided in computer format at the knowledge. Some questions test the examinee’s fund
USMLE website and on CD, you must run the tutorial of information per se, but the majority of questions
and sample materials to become familiar with the test require the examinee to interpret graphic and tabular
software prior to your test date. material, to identify gross and microscopic pathologic
and normal specimens, and to solve problems through
The Step 1 examination consists of questions ("test application of basic science principles.
items") presented in standard multiple-choice formats,
as described on page 4 of this booklet. The test items Step 1 is constructed from an integrated content
are divided into "blocks" (see Test Lengths and outline that organizes basic science content according
Formats on page 9 of the Bulletin). You may want to to general principles and individual organ systems. Test
study the descriptions of test item formats that follow questions are classified in one of these major areas
before you run the sample test items. A Normal depending on whether they focus on concepts and
Laboratory Values Table, including Standard principles that are important across organ systems or
International conversions, is reproduced on pages 21 within individual organ systems.
and 22 of this booklet. This table will be available as an
on-line reference when you take the examination.
3
Sections focusing on individual organ systems are Strategies for Answering Single One Best Answer
subdivided according to normal and abnormal pro- Test Questions
cesses, principles of therapy, and psychosocial, cul-
tural, and environmental considerations. Each exami- # Read each question carefully. It is important to
nation covers content related to the traditionally understand what is being asked.
defined disciplines of anatomy, behavioral sciences, # Try to generate an answer and then look for it in
biochemistry, microbiology, pathology, pharmacology, the option list.
and physiology, as well as to interdisciplinary areas
# Alternatively, read each option carefully, eliminat-
including genetics, aging, immunology, nutrition, and
ing those that are clearly incorrect.
molecular and cell biology. While not all topics listed in
the content outline are included in every examination, # Of the remaining options, select the one that is
overall content coverage is comparable in the various most correct.
examination forms that will be taken by different # If unsure about an answer, it is better to guess
examinees. since unanswered questions are automatically
counted as wrong answers.
A full content outline for the USMLE Step 1 examina-
tion is provided on pages 6 to 19. It describes the
scope of the examination in detail. To facilitate review, Example Item
the major categories are indicated in bold type, with
the subcategories in regular type. A 32-year-old woman with type 1 diabetes
mellitus has had progressive renal failure over the
The content outline is not intended as a curriculum past 2 years. She has not yet started dialysis.
development or study guide. It provides a flexible Examination shows no abnormalities. Her hemo-
structure for test construction that can readily globin concentration is 9 g/dL, hematocrit is 28%,
accommodate new topics, emerging content domains, and mean corpuscular volume is 94 µm3 . A blood
and shifts in emphasis. The categorizations and content smear shows normochromic, normocytic cells.
coverage are subject to change. Broadly based learn- Which of the following is the most likely cause?
ing that establishes a strong general understanding of
concepts and principles in the basic sciences is the (A) Acute blood loss
best preparation for the examination. (B) Chronic lymphocytic leukemia
(C) Erythrocyte enzyme deficiency
(D) Erythropoietin deficiency
Step 1 Test Question Format (E) Immunohemolysis
(F) Microangiopathic hemolysis
Single One Best Answer Questions (G) Polycythemia vera
Step 1 includes only single questions with one best (H) Sickle cell disease
answer. This is the traditional, most frequently used (I) Sideroblastic anemia
multiple-choice format. These items consist of a (J) ß-Thalassemia trait
statement or question followed by three to eleven
response options arranged in alphabetical or logical
(Answer: D)
order. A portion of the questions involves interpretation
of graphic or pictorial materials. The response options
for all questions are lettered (eg, A, B, C, D, E).
Examinees are required to select the best answer to
the question. Other options may be partially correct,
but there is only ONE BEST answer.
4
Step 1 Content Outline
Table of Contents
General Principles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Biochemistry and Molecular Biology
Biology of Cells
Human Development and Genetics
Biology of Tissue Response to Disease
Gender, Ethnic, and Behavioral Considerations Affecting Disease Treatment and Prevention
Multisystem Processes
Pharmacodynamic and Pharmacokinetic Processes
Microbial Biology and Infection
Immune Responses
Quantitative Methods
Examples of diseases and normal processes are listed within this content outline. The purpose of these examples
is only to clarify and illustrate the particular categories they are appended to; they are not intended to direct the
examinee toward preparing for questions on them. Examinees should not focus their studies on the examples only.
The examination encompasses the categories in the content outline, but the examination will not be limited to or
emphasize the examples or the categories for which examples are given.
5
General Principles
Biology of cells
# signal transduction: second messenger systems – voltage- and ligand-gated channels and receptors
# cell components (eg, endoplasmic reticulum, plasma membrane, nucleus)
# cytoskeleton (including cell movement and intracellular transport)
# secretion and exocytosis, endocytosis, transcytosis
# cell cycle, mitosis, meiosis, structure and regulation of spindle apparatus, control points
# epithelial cells (including surface specialization, intercellular junctions, gap junctions, and desmosomes)
# fibroblasts, endothelial cells, and mesenchymal cells: basement membrane, extracellular matrix,
proteoglycans, fibronectins, adhesion molecules, annexins
# muscle cells (cardiac, smooth, skeletal): structure and regulation of contractile elements, excitation-
contraction coupling
# adaptive cell response to injury (eg, hypertrophy, metaplasia)
6
# mechanisms of cell injury and necrosis (including free radical mediated cell injury)
# apoptosis (programmed cell death)
Gender, ethnic, and behavioral considerations affecting disease treatment and prevention (including psychosocial,
cultural, occupational, and environmental)
# progression through the life cycle (birth through senescence)
– cognitive, language, motor skills, and social and interpersonal development
– sexual development (eg, puberty, menopause)
– influence of developmental stage on physician/patient interview
# psychologic and social factors influencing patient behavior
– personality traits or coping style (coping mechanisms)
– psychodynamic and behavioral factors, related past experience
– family and cultural factors, including socioeconomic status, ethnicity, and gender
– adaptive and maladaptive behavioral responses to stress and illness (eg, drug-seeking behavior,
sleep deprivation)
– interactions between the patient and the physician or the health care system (eg, transference)
– patient adherence (general and adolescent)
# patient interviewing, consultation, and interactions with the family
– establishing and maintaining rapport
– data gathering
– approaches to patient education
– enticing patients to make life style changes
– communicating bad news
– “difficult” interviews (eg, anxious or angry patients)
– multicultural ethnic characteristics
# medical ethics, jurisprudence, and professional behavior
– consent and informed consent to treatment
– physician-patient relationships (eg, ethical conduct, confidentiality)
7
– death and dying
– birth-related issues
– issues related to patient participation in research
– interactions with other health professionals (eg, referral)
– sexuality and the profession, other “boundary” issues
– ethics of managed care
– organization and cost of health-care delivery
Multisystem processes
# nutrition
– generation, expenditure, and storage of energy at the whole-body level
– assessment of nutritional status across the life span (eg, calories, protein, essential nutrients,
hypoalimentation
– functions of nutrients (essential, transfatty acids, cholesterol)
– protein-calorie malnutrition
– vitamin deficiencies and/or toxicities
– mineral deficiencies and toxicities
– eating disorders (eg, obesity, anorexia, bulimia)
# temperature regulation
# adaptation to environmental extremes (including occupational exposures)
– physical and associated disorders (eg, temperature; radiation; burns; decreased atmospheric
pressure; high altitude sickness; increased water pressure)
– chemical (eg, gases, vapors; smoke inhalation; agricultural hazards, volatile organic solvents, heavy
metals; principles of poisoning and therapy)
# fluid, electrolyte, and acid-base balance and disorders (eg, dehydration, acidosis, alkalosis)
Immune responses
# production and function of granulocytes, natural killer cells, macrophages
# production and function of T lymphocytes, T lymphocyte receptors
# production and function of B lymphocytes and plasma cells; immunoglobulin and antibodies: structure
and biologic properties
# antigenicity and immunogenicity; antigen presentation; cell activation and regulation; tolerance and
clonal deletion
# immunologic mediators: chemistry, function, molecular biology, classic and alternative complement
pathways, cytokines, chemokines
# immunogenetics; MHC structure and function, class I, II molecules; erythrocyte antigens; transplantation
# immunizations: vaccines, protective immunity
# alterations in immunologic function
– T or B lymphocyte deficiencies
– deficiencies of phagocytic cells
– combined immunodeficiency disease
– HIV infection/AIDS and other acquired disorders of immune responsiveness
– drug-induced alterations in immune responses, immunopharmacology
# immunologically mediated disorders
– hypersensitivity (types I–IV)
– transplant rejection
– autoimmune disorders
– risks of transplantation, transfusion (eg, graft-versus-host disease)
– isoimmunization, hemolytic disease of the newborn
– immunopathogenesis
# immunologic principles underlying diagnostic laboratory tests (eg, ELISA, complement fixation, RIA,
agglutination)
Quantitative methods
# fundamental concepts of measurement
– scales of measurement
– distribution, central tendency, variability, probability
– disease prevalence and incidence
– disease outcomes (eg, fatality rates)
– associations (correlation or covariance)
– health impact (eg, risk differences and ratios)
– sensitivity, specificity, predictive values
# fundamental concepts of study design
– types of experimental studies (eg, clinical trials, community intervention trials)
– types of observational studies (eg, cohort, case-control, cross-sectional, case series, community
surveys)
– sampling and sample size
– subject selection and exposure allocation (eg, randomization, stratification, self-selection, systematic
assignment)
– outcome assessment
9
– internal and external validity
# fundamental concepts of hypothesis testing and statistical inference
– confidence intervals
– statistical significance and type I error
– statistical power and type II error
Normal processes
# embryonic development, fetal maturation, and perinatal changes
# organ structure and function
# cell/tissue structure and function
– production and function of erythrocytes, hemoglobin, O2 and CO2 transport, transport proteins
– production and function of leukocytes and the lymphoreticular system
– production and function of platelets
– production and function of coagulation and fibrinolytic factors
# repair, regeneration, and changes associated with stage of life
Abnormal processes
# infectious, inflammatory, and immunologic disorders
– infections of the blood, reticuloendothelial system, and lymphatics
– allergic and anaphylactic reactions and other immunopathologic mechanisms
– acquired disorders of immune deficiency
– autoimmunity and autoimmune diseases (eg, Coombs’ positive hemolytic anemia, pernicious anemia,
cryoglobulinemias, ITP)
– anemia of chronic disease
– transfusion complications, transplant rejection
# traumatic and mechanical injury (eg, mechanical injury to erythrocytes, splenic rupture)
# neoplastic disorders (eg, lymphoma, leukemia, multiple myeloma)
# metabolic and regulatory disorders (acquired and congenital)
– anemias and cytopenias (eg, iron deficiency anemia, hemoglobinopathies, hereditary spherocytosis)
– cythemia
– hemorrhagic and hemostatic disorders (eg, coagulopathies, DIC)
– bleeding secondary to platelet disorders (von Willebrand's)
# vascular and endothelial disorders (eg, effects and complications of splenectomy, hypersplenism, TTP,
hemolytic-uremic syndrome)
# systemic disorders affecting the hematopoietic and lymphoreticular system (eg, nutritional deficiencies,
systemic lupus erythematosus)
# idiopathic disorders
Principles of therapeutics
# mechanisms of action, use, and adverse effects of drugs for treatment of disorders of the hematopoietic
system
– blood and blood products
– treatment of anemia, drugs stimulating erythrocyte production (eg, erythropoietin)
– drugs stimulating leukocyte production (eg, G-CSF, GM-CSF)
– anticoagulants, thrombolytic drugs
– antiplatelet drugs
– antimicrobials (eg, antimalarials, anti-HIV)
– antineoplastic and immunosuppressive drugs
– drugs used to treat acquired disorders of immune responsiveness
# other therapeutic modalities (eg, splenectomy, chelating agents, radiation therapy for lymphomas,
plasmapheresis)
Gender, ethnic, and behavioral considerations affecting disease treatment and prevention (including psychosocial,
cultural, occupational, and environmental)
# emotional and behavioral factors (eg, diet, depression and immune responses, “blood doping” among
athletes)
10
# influence on person, family, and society (eg, childhood leukemia)
# occupational and other environmental risk factors (eg, heavy metals, hydrocarbons, lead)
# gender and ethnic factors (eg, herbal treatments with bone marrow depression)
Normal processes
# embryonic development, fetal maturation, and perinatal changes (eg, neural tube derivatives, cerebral
ventricles, neural crest derivatives)
# organ structure and function
– spinal cord (including gross anatomy, blood supply, and spinal reflexes)
– brain stem (including cranial nerves and nuclei, reticular formation, gross anatomy, and blood
supply)
– brain (including gross anatomy and blood supply; cognition, language, memory; hypothalamic
function; limbic system and emotional behavior; circadian rhythms and sleep; and control of eye
movement)
– sensory systems (including proprioception, pain, vision, hearing, balance, taste, and olfaction)
– motor systems (brain and spinal cord, basal ganglia and cerebellum)
– autonomic nervous system
– peripheral nerves
# cell/tissue structure and function
– axonal transport
– excitable properties of neurons, axons and dendrites, including channels
– synthesis, storage, release, reuptake, and degradation of neurotransmitters and neuromodulators
– pre- and postsynaptic receptor interactions, trophic and growth factors
– brain metabolism
– glia, myelin
– brain homeostasis: blood-brain barrier; cerebrospinal fluid formation and flow, choroid plexus
# repair, regeneration and changes associated with stage of life
Abnormal processes
# infectious, inflammatory, and immunologic disorders (eg, meningitis, multiple sclerosis, myasthenia
gravis)
# traumatic and mechanical disorders (subdural and epidural hematomas, cord compression, peripheral
nerve injury)
# neoplastic disorders (primary and metastatic)
# acquired metabolic and regulatory disorders (eg, delirium, Reye’s syndrome)
# vascular disorders (eg, cerebrovascular occlusion, venous sinus thrombosis, arterial aneurysms,
hemorrhage)
# systemic disorders affecting the nervous system (eg, lupus, diabetic neuropathy)
# idiopathic disorders affecting the nervous system
# congenital disorders, including metabolic (eg, neural tube defects, cerebral palsy, mental retardation,
Down’s syndrome)
# degenerative disorders (eg, peripheral neuropathy, Alzheimer's dementia, Parkinson's disease, Hunting-
ton's disease, amyotrophic lateral sclerosis)
# paroxysmal disorders (eg, epilepsy, headache, pain syndromes, and sleep disorders including narcolepsy,
restless legs syndrome/periodic limb movement, circadian rhythm disorders, parasomnias)
# disorders of special senses (eg, blindness, deafness)
# psychopathologic disorders, processes and their evaluation
– early-onset disorders (eg, learning disorders)
– disorders related to substance use
– schizophrenia and other psychotic disorders
– mood disorders
– anxiety disorders
– somatoform disorders
– personality disorders
– physical and sexual abuse of children, adults, and elders
– other disorders (eg, dissociative, impulse control, posttraumatic stress disorder)
11
Principles of therapeutics
# mechanisms of action, use, and adverse effects of drugs for treatment of disorders of the nervous system
– anesthetics
– hypnotics
– psychopharmacologic agents (eg, anxiolytics, antidepressants, antipsychotic agents, mood-
stabilizing agents)
– anticonvulsants
– analgesics
– stimulants, amphetamines
– antiparkinsonian drugs
– skeletal muscle relaxants, botulinum toxin
– neuromuscular junction blocking agents
– antiglaucoma drugs
– drugs used to decrease intracranial pressure (eg, mannitol, high-dose glucocorticoids)
– antimigraine agents
– drugs affecting autonomic nervous system (eg, anticholinesterases)
# other therapeutic modalities (eg, radiation, CFS shunting, surgery)
Gender, ethnic, and behavioral considerations affecting disease treatment and prevention (including psychosocial,
cultural, occupational, and environmental)
# emotional and behavioral factors (eg, drug abuse, dementia, sleep deprivation, accident prevention, pets)
# influence on person, family, and society (eg, developmental disabilities, dementia, generational reversal,
nutrition, seizures, sleep disorders)
# occupational and other environmental risk factors (eg, boxing, carbon monoxide exposure)
# gender and ethnic factors
Normal processes
# embryonic development, fetal maturation, and perinatal changes
# organ structure and function
# cell/tissue structure and function (eg, barrier functions, thermal regulation, eccrine function)
# repair, regeneration, and changes associated with stage of life or ethnicity (eg, senile purpura, male
pattern baldness, postmenopausal hair changes)
# skin defense mechanisms and normal flora
Abnormal processes
# infectious, inflammatory, and immunologic disorders
– bacterial infections, (eg, acne, cellulitis, carbuncle, abscess, necrotizing fasciitis, gangrene)
– viral infections (eg, herpes infections, chickenpox, rubella, measles, roseola, verrucae)
– fungal infections, including mycoses, dermatophytosis (eg, tinea)
– parasitic infections (eg, scabies, lice)
– immune and autoimmune disorders (eg, discoid lupus erythematosus, scleroderma, dermatomyositis,
alopecia, psoriasis, urticaria, allergic dermatosis)
# traumatic and mechanical disorders (eg, thermal injury, decubitus ulcers, effects of ultraviolet light and
radiation)
# neoplastic disorders
– keratinocytes (eg, seborrheic keratosis, actinic keratosis, basal cell carcinoma, squamous cell
carcinoma)
– melanocytes (eg, nevi, melanoma, ichthyosis)
– vascular neoplasms (eg, hemangiomas, Kaposi’s sarcoma)
– other (eg, T-cell lymphoma, skin appendage tumors)
# metabolic, regulatory, and structural disorders (eg, vitamin deficiencies, hypervitaminosis, hyperhidrosis)
# vascular disorders (eg, vasculitis, Raynaud's disease)
# systemic disorders affecting the skin (eg, Ehlers-Danlos syndrome, Marfan’s syndrome)
Principles of therapeutics
# mechanisms of action, use, and adverse effects of drugs for treatment of disorders of the skin and
12
connective tissue (including anti-inflammatory agents (eg, steroids, antihistamines), emollients,
sunscreen, retin-A, antimicrobial agents, cytotoxic therapy (eg, methotrexate, PUVA, keratinolytics)
# other therapeutic modalities (eg, laser, tattoo removal, cryotherapy)
Gender, ethnic, and behavioral considerations affecting disease treatment and prevention (including psychosocial,
cultural, occupational, and environmental)
# emotional and behavioral factors (eg, sun exposure, acne)
# influence on person, family, and society (eg, psoriasis)
# occupational and other environmental risk factors
# gender and ethnic factors (eg, keloid)
Musculoskeletal system
Normal processes
# embryonic development, fetal maturation, and perinatal changes
# organ structure and function
# cell/tissue structure and function
– biology of bones, joints, tendons, skeletal muscle
– exercise and physical conditioning
# repair, regeneration, and changes associated with stage of life
Abnormal processes
# infectious, inflammatory, and immunologic disorders
– infectious disorders (eg, septic arthritis, Lyme disease, osteomyelitis)
– inflammatory disorders (eg, fibrositis, synovitis, tenosynovitis)
– immunologic disorders (eg, rheumatoid arthritis, ankylosing spondylitis, polymyositis, systemic
lupus erythematosus, dermatomyositis, polymyalgia rheumatica)
# traumatic and mechanical disorders (eg, fractures, sprains, strains, dislocations, repetitive motion injuries)
# neoplastic disorders (eg, osteosarcoma, metastatic disease)
# metabolic, regulatory, and structural disorders (eg, dwarfism, osteogenesis imperfecta, osteomalacia,
osteoporosis, osteodystrophy, gout)
# vascular disorders (eg, polyarteritis nodosa, bone infarcts)
# systemic disorders affecting the musculoskeletal system (eg, diabetes mellitus)
# idiopathic disorders (eg, Dupuytren's contracture, scoliosis, Paget's disease)
# degenerative disorders (eg, disc disease, osteoarthritis)
Principles of therapeutics
# mechanisms of action, use, and adverse effects of drugs for treatment of disorders of the musculoskeletal
system
– nonsteroidal anti-inflammatory drugs
– muscle relaxants
– antigout therapy (eg, allopurinol, colchicine, uricosuric drugs)
– immunosuppressive drugs (eg, glucocorticoids, gold, cytotoxic agents)
– drugs affecting bone mineralization (eg, diphosphonates, calcitonin, estrogen analogs)
# other therapeutic modalities (eg, radiation, surgery, casts, rehabilitation)
Gender, ethnic, and behavioral considerations affecting disease treatment and prevention (including psychosocial,
cultural, occupational, and environmental)
# emotional and behavioral factors (eg, diet, exercise, seat belts, bicycle helmets)
# influence on person, family, and society (eg, osteoporosis, fractures in elderly, alcohol abuse, fractures)
# occupational and other environmental risk factors (eg, athletes, musicians)
# gender and ethnic factors (eg, bone mass)
Respiratory system
Normal processes
# embryonic development, fetal maturation, and perinatal changes
# organ structure and function
13
– airways (eg, mechanics and regulation of breathing)
– lung parenchyma (eg, ventilation, perfusion, gas exchange)
– pleura
# cell/tissue structure and function (eg, surfactant formation, alveolar structure)
# repair, regeneration, and changes associated with stage of life
# pulmonary defense mechanisms and normal flora
Abnormal processes
# infectious, inflammatory, and immunologic disorders
– infectious diseases of the upper and lower respiratory tract and pleura and their complications (eg,
bronchiectasis, abscess, empyema)
– immunologic disorders
– allergic and hypersensitivity disorders (eg, asthma)
– autoimmune disorders (eg, Wegener’s granulomatosis, Goodpasture’s syndrome)
– inflammatory disorders
– pneumoconioses
– acute and chronic alveolar injury (eg, adult respiratory distress syndrome, chlorine gas/smoke
inhalation)
– obstructive pulmonary disease
– restrictive pulmonary disease (eg, sarcoidosis, idiopathic fibrosis)
# traumatic and mechanical disorders (eg, aspiration, pneumothorax, atelectasis, sleep apnea)
# neoplastic disorders (eg, polyps, bronchogenic carcinoma, mesothelioma, metastatic tumors)
# metabolic, regulatory, and structural disorders (eg, hypoventilation, disorders of gas exchange,
ventilation-perfusion imbalance, neonatal respiratory distress syndrome)
# vascular and circulatory disorders (eg, thromboembolic disease, pulmonary hypertension, pulmonary
edema, pleural effusion)
# systemic disorders affecting the respiratory system
Principles of therapeutics
# mechanisms of action, use, and adverse effects of drugs for treatment of disorders of the respiratory
system (eg, decongestants, cough suppressants, expectorants, mucolytics
bronchodilator drugs, anti-inflammatory and cytotoxic drugs, antimicrobial agents, antineoplastic agents)
# other therapeutic modalities (eg, oxygen therapy, nasal CPAP, mechanical ventilation, physical therapy,
surgical procedures, including transplantation)
Gender, ethnic, and behavioral considerations affecting disease treatment and prevention (including psychosocial,
cultural, occupational, and environmental)
# emotional and behavioral factors (eg, smoking, substance abuse, pets, allergies)
# influence on person, family, and society (eg, tuberculosis, asthma, chronic obstructive pulmonary
disease, school issues, protective parents, family smoking)
# occupational and other environmental risk factors
# gender and ethnic factors (eg, sarcoidosis, lung cancer)
Cardiovascular system
Normal processes
# embryonic development, fetal maturation, and perinatal changes
# organ structure and function
– chambers, valves
– cardiac cycle, mechanics, heart sounds, cardiac output
– hemodynamics (systemic, pulmonary, coronary) and blood volume
– circulation in specific vascular beds
# cell/tissue structure and function
– heart muscle, metabolism, oxygen consumption, biochemistry, and secretory function (eg, atrial
natriuretic peptide)
– endothelium and secretory function, vascular smooth muscle, microcirculation, and lymph flow
– mechanisms of atherosclerosis
– neural and hormonal regulation of the heart, blood vessels, and blood volume, including responses
14
to change in posture, exercise, and tissue metabolism
# repair, regeneration, and changes associated with stage of life
Abnormal processes
# infectious, inflammatory, and immunologic disorders
– infectious disorders (eg, endocarditis, myocarditis, pericarditis )
– inflammatory and immunologic disorders (eg, acute rheumatic fever, systemic lupus erythematosus,
transplant rejection, vasculitis, temporal arteritis)
# traumatic and mechanical disorders (eg, tamponade, valvular disease, subaortic stenosis)
# neoplastic disorders
# metabolic and regulatory disorders (eg, dysrhythmias, systolic and diastolic dysfunction, low- and high-
output heart failure, cor pulmonale, systemic hypertension, ischemic heart disease, myocardial infarction,
systemic hypotension, shock)
# vascular disorders (eg, aneurysms, occlusions, varicosities, atherosclerosis)
# systemic diseases affecting the cardiovascular system (eg, amyloidosis, aortic dissection with Marfan
syndrome, hemochromatosis, scleroderma)
# congenital disorders of the heart and central vessels
Principles of therapeutics
# mechanisms of action, use, and adverse effects of drugs for treatment of disorders of the cardiovascular
system
– coronary and peripheral vasodilators
– antiarrhythmic drugs
– antihypertensive drugs
– measures used to combat hypotension and shock
– drugs affecting cholesterol and lipid metabolism
– drugs affecting blood coagulation, thrombolytic agents
– inotropic agents and treatment of heart failure
– immunosuppressive and antimicrobial drugs
– drugs to treat peripheral arterial disease
# other therapeutic modalities (eg, pacemakers, angioplasty, valves, grafts, other surgical procedures)
Gender, ethnic, and behavioral considerations affecting disease treatment and prevention (including psychosocial,
cultural, occupational, and environmental)
# emotional and behavioral factors (eg, smoking, alcohol, ischemic heart disease, obesity, exercise, diet)
# influence on person, family, and society (eg, altered lifestyle)
# occupational and other environmental risk factors (eg, stress)
# gender and ethnic factors (eg, hypertension)
Gastrointestinal system
Normal processes
# embryonic development, fetal maturation, and perinatal changes
# organ structure and function (eg, alimentary canal, liver and biliary system, salivary glands and exocrine
pancreas, motility, digestion and absorption)
# cell/tissue structure and function
– endocrine and neural regulatory functions, including GI hormones)
– salivary, gastrointestinal, pancreatic, hepatic secretory products (eg, enzymes, proteins, bile salts)
and processes
– synthetic and metabolic functions of hepatocytes
# repair, regeneration, and changes associated with stage of life
# gastrointestinal defense mechanisms and normal flora
Abnormal processes
# infectious, inflammatory, and immunologic disorders
– infectious disorders (eg, peritonitis, hepatitis, gingivostomatitis, peptic ulcer, gastritis, esophagitis,
traveler’s diarrhea, food poisoning)
– inflammatory disorders (eg, cholecystitis, pancreatitis)
15
– immunologic disorders (eg, Crohn's disease, ulcerative colitis)
# traumatic and mechanical disorders
– malocclusion
– hiatus hernia
– obstruction (eg, volvulus, intussusception, esophageal atresia, annular pancreas, post-surgical
obstruction)
– perforation of hollow viscus and blunt trauma
– inguinal, femoral, and abdominal wall hernias
– esophageal and colonic diverticula (eg, Meckel's diverticulum)
# neoplastic disorders (benign and malignant)
# metabolic and regulatory disorders (eg, motility disorders, malabsorption, hepatic failure, cholelithiasis)
# vascular disorders (eg, portal hypertension, hemorrhoids, ischemia, angiodysplasia)
# systemic disorders affecting the gastrointestinal system
Principles of therapeutics
# mechanisms of action, use, and adverse effects of drugs for treatment of disorders of the gastrointestinal
system
– treatment and prophylaxis of peptic ulcer disease and gastroesophageal reflux (eg, antacids,
antisecretory drugs, motility drugs, mucosal protective agents, antibiotics)
– drugs to alter gastrointestinal motility (eg, cathartics, antidiarrheal drugs, antiemetic drugs, prokinetic
drugs)
– fluid replacement (eg, oral rehydration)
– pancreatic replacement therapy and treatment of pancreatitis
– drugs for treatment of hepatic failure (eg, lactulose) and biliary disease (eg, drugs to dissolve
gallstones)
– anti-inflammatory, immunosuppressive, antineoplastic, and antimicrobial drugs
# other therapeutic modalities (eg, surgical procedures, stents, feeding tubes)
Gender, ethnic, and behavioral considerations affecting disease treatment and prevention (including psychosocial,
cultural, occupational, and environmental)
# emotional and behavioral factors (eg, peptic ulcer, encopresis, Monday morning stomach)
# influence on person, family, and society (eg, inflammatory bowel disease, irritable bowel disease,
pancreatitis and alcohol, chronic laxative abuse)
# occupational and other environmental risk factors
# gender and ethnic factors (eg, diets)
Renal/urinary system
Normal processes
# embryonic development, fetal maturation, and perinatal changes
# organ structure and function
– kidneys, ureters, bladder, urethra
– glomerular filtration and hemodynamics
– tubular reabsorption and secretion, including transport processes and proteins
– urinary concentration and dilution
– renal mechanisms in acid-base balance
– renal mechanisms in body fluid homeostasis
– micturition
# cell/tissue structure and function (eg, renal metabolism and oxygen consumption, hormones produced by
or acting on the kidney)
# repair, regeneration, and changes associated with stage of life
Abnormal processes
# infectious, inflammatory, and immunologic disorders
– infectious disorders
– upper urinary tract (eg, pyelonephritis, papillary necrosis)
– lower urinary tract (eg, cystitis, urethritis)
– inflammatory and immunologic disorders
16
– glomerular disorders (eg, glomerulonephritis, nephrotic syndrome)
– tubular interstitial disease (eg, interstitial nephritis, transplant rejection, IgA nephropathy)
# traumatic and mechanical disorders (eg, obstructive uropathy)
# neoplastic disorders (eg, renal, urinary bladder and collecting system, metastases)
# metabolic and regulatory disorders
– renal failure, acute and chronic (acute tubular necrosis)
– tubular and collecting duct disorders (eg, Fanconi’s syndrome, renal tubular acidosis, nephrogenic
diabetes insipidus)
– renal calculi
# vascular disorders (eg, renal artery stenosis)
# systemic diseases affecting the renal system (eg, diabetes mellitus, hepatitis, amyloidosis, systemic lupus
erythematosus, Wegener's granulomatosis)
Principles of therapeutics
# mechanisms of action, use, and adverse effects of drugs for treatment of disorders of the renal and
urinary system
– diuretics, antidiuretic drugs
– drugs and fluids used to treat volume, electrolyte, and acid-base disorders
– drugs used to enhance renal perfusion (eg, dopamine)
– anti-inflammatory, antimicrobial, immunosuppressive, and antineoplastic drugs
# other therapeutic modalities (eg, dialysis, renal transplantation)
Gender, ethnic, and behavioral considerations affecting disease treatment and prevention (including psychosocial,
cultural, occupational, and environmental)
# emotional and behavioral factors (eg, drug-induced interstitial nephritis, diet)
# influence on person, family, and society (eg, hemodialysis, living related kidney donation, transplants)
# occupational and other environmental risk factors (eg, heavy metals)
# gender and ethnic factors (eg, disease progression, urinary tract infections)
Reproductive system
Normal processes
# embryonic development, fetal maturation, and perinatal changes
# organ structure and function
– female structure (including breast)
– female function (eg, menstrual cycle, puberty, menopause)
– male structure
– male function (eg, spermatogenesis, puberty)
– intercourse, orgasm (male and female)
– pregnancy (including labor and delivery, the puerperium, lactation, gestational uterus, placenta)
# cell/tissue structure and function (including hypothalamic-pituitary-gonadal axis, sex steroids, and
gestational hormones)
# reproductive system defense mechanisms and normal flora
Abnormal processes
# infectious, inflammatory, and immunologic disorders (eg, toxic shock syndrome, breast abscess, orchitis,
sexually transmitted diseases, autoimmune hypogonadism, cystic mastitis)
# traumatic and mechanical disorders (eg, female incontinence, torsion of testis, varicocele)
# neoplastic disorders (eg, female reproductive, male reproductive, breast [male and female, including
fibrocystic disease], trophoblastic disease)
# metabolic and regulatory processes
– female (eg, anovulation, infertility, polycystic ovaries, endometriosis, orgasmic dysfunction, delayed
and premature puberty)
– menopausal syndrome
– male (eg, infertility, impotence, gynecomastia, delayed and premature puberty)
– benign prostatic hyperplasia
# systemic disorders affecting reproductive function (eg, obesity, myotonic dystrophy, cirrhosis, renal
failure)
17
# disorders relating to pregnancy, the puerperium, and the postpartum period
– obstetric problems (eg, ectopic pregnancy, third trimester bleeding)
– complications affecting other organ systems (eg, eclampsia, gestational diabetes, thyroid disorders)
– disorders associated with the puerperium (eg, postpartum hemorrhage, sepsis, depression)
– antepartum, intrapartum, postpartum disorders of the fetus (eg, prematurity, postmaturity, cord
compression, macrosomia)
Principles of therapeutics
# mechanisms of action, use, and adverse effects of drugs for treatment of disorders of the reproductive
system and management of normal reproductive function
– female reproductive tract
– fertility drugs
– oral contraception, other methods of contraception (eg, condoms)
– estrogen, progestogen replacement
– stimulants and inhibitors of labor
– estrogen and progesterone antagonists, treatment of menopause
– stimulators and inhibitors of lactation
– male reproductive tract
– fertility drugs
– androgen replacement and antagonists
– gonadotropin-releasing hormone and gonadotropin replacement
– abortifacients
– antimicrobials
– antineoplastics
– restoration of potency
# other therapeutic modalities affecting the reproductive system (eg, tampons, anabolic steroids)
Gender, ethnic, and behavioral considerations affecting disease treatment and prevention (including psychosocial,
cultural, occupational, and environmental)
# emotional and behavioral factors(eg, sexually transmitted diseases)
# influence on person, family, and society (eg, infertility)
# occupational and other environmental risk factors (eg, radiation)
# family planning and pregnancy (eg, unwanted)
# gender identity, sexual orientation, sexuality, libido
# effects of traumatic stress syndrome, violence, rape, child abuse
Endocrine system
Normal processes
# embryonic development, fetal maturation, and perinatal changes
# organ structure and function
– hypothalamus, posterior and anterior pituitary gland
– thyroid gland
– parathyroid glands
– adrenal cortex, adrenal medulla
– pancreatic islets
– ovary and testis
– adipose tissue
# cell/tissue structure and function (eg, hormone synthesis, secretion, action, and metabolism)
– peptide hormones
– steroid hormones, including vitamin D
– thyroid hormones
– catecholamine hormones
– renin-angiotensin system
# repair, regeneration, and changes associated with stage of life
Abnormal processes
# infectious, inflammatory, and immunologic disorders (eg, subacute thyroiditis, Graves’ disease,
18
sarcoidosis)
# traumatic and mechanical disorders
# neoplastic disorders (eg, pituitary, thyroid, parathyroid, adrenal cortex, pancreatic islets, neural crest,
pheochromocytoma)
# metabolic and regulatory processes (eg, diabetes mellitus, pituitary, hypothalamus, thyroid, parathyroid,
pancreatic islet disorders, adrenal disorders)
# vascular disorders (eg, pituitary apoplexy)
# systemic disorders affecting the endocrine system (eg, hemochromatosis)
# idiopathic disorders (eg, hirsutism)
Principles of therapeutics
# mechanisms of action, use, and adverse effects of drugs for treatment of disorders of the endocrine
system
– hormones and hormone analogs
– stimulators of hormone production (eg, sulfonylureas)
– inhibitors of hormone production (eg, thiouracils)
– hormone antagonists
– potentiators of hormone action (eg, thiazolidinediones, demeclocycline)
– antiobesity agents (eg, dexfenfluramine)
# other therapeutic modalities (eg, surgery, radiation)
Gender, ethnic, and behavioral considerations affecting disease treatment and prevention (including psychosocial,
cultural, occupational, and environmental)
# emotional and behavioral factors (eg, compliance in diabetes mellitus, factitious use of insulin, psycho-
genic polydipsia)
# influence on person, family, and society
# occupational and other environmental risk factors (eg, radiation exposure, iodine deficiency)
# gender and ethnic factors
19
Sample Step 1
Sample Questions
The following pages include 150 sample test questions. These questions are the same as those you install on your
computer from the USMLE website or CD. For information on obtaining the test software and additional
information on preparing to take the test and testing, you must review the 2003 USMLE Bulletin of Information:
see Preparing for the Test (pages 9-10) and Testing (pages 16-19). Please note that reviewing the sample questions
as they appear on pages 24-48 is not a substitute for acquainting yourself with the test software. You should run
the Step 1 tutorial and sample test questions that are provided on the USMLE website or CD well before your test
date.
These sample questions are illustrative of the types of questions used in the Step 1 examination. Although the
questions exemplify content on the examination, they may not reflect the content coverage on individual
examinations. In the actual examination, questions may appear randomly; they will not be grouped according to
specific content. The questions will be presented one at a time in a format designed for easy on-screen reading,
including use of exhibit buttons (separate windows) for the Normal Laboratory Values Table (included here on
pages 21-22) and some pictorials. Photographs, charts, and x-ray films referred to in this booklet are not of the
same quality as the pictorials used in the actual examination. In addition, you will have the capability to adjust the
brightness and contrast of pictorials on the computer screen.
To take the following sample test questions as they would be timed in the actual examination, you should allow a
maximum of one hour for each block, for a total of three hours. Please be aware that most examinees perceive
the time pressure to be greater during an actual examination. An answer form for recording answers is provided
on page 23. In the actual examination, answers will be selected on the screen; no answer form will be provided.
An answer key is provided on page 49.
20
USMLE Step1 Laboratory Values
* Included in the Biochemical Profile (SMA-12)
REFERENCE RANGE SI REFERENCE INTERVALS
BLOOD, PLASMA, SERUM
* Alanine aminotransferase (ALT, GPT at 30 C) . . . . . . . . . . . . . 8-20 U/L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8-20 U/L
Amylase, serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25-125 U/L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25-125 U/L
* Aspartate aminotransferase (AST, GOT at 30 C) . . . . . . . . . . 8-20 U/L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8-20 U/L
Bilirubin, serum (adult) Total // Direct . . . . . . . . . . . . . . . . . . . . 0.1-1.0 mg/dL // 0.0-0.3 mg/dL . . . . . . . . . . . . . . . 2-17 µmol/L // 0-5 µmol/L
* Calcium, serum (Ca2+) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.4-10.2 mg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.1-2.8 mmol/L
* Cholesterol, serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Rec:<200 mg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . <5.2 mmol/L
Cortisol, serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0800 h: 5-23 µg/dL // 1600 h: 3-15 µg/dL . . . . . . . 138-635 nmol/L // 82-413 nmol/L
2000 h: < 50% of 0800 h . . . . . . . . . . . . . . . . . . . . Fraction of 0800 h: < 0.50
Creatine kinase, serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Male: 25-90 U/L . . . . . . . . . . . . . . . . . . . . . . . . . . 25-90 U/L
Female: 10-70 U/L . . . . . . . . . . . . . . . . . . . . . . . . 10-70 U/L
* Creatinine, serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.6-1.2 mg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53-106 µmol/L
Electrolytes, serum
Sodium (Na+) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136-145 mEq/L . . . . . . . . . . . . . . . . . . . . . . . . . . . 136-145 mmol/L
Chloride (Cl-) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95-105 mEq/L . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95-105 mmol/L
* Potassium (K+) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.5-5.0 mEq/L . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.5-5.0 mmol/L
Bicarbonate (HCO3 -) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22-28 mEq/L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22-28 mmol/L
Magnesium (Mg2+) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.5-2.0 mEq/L . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.5-2.0 mmol/L
Estriol, total, serum (in pregnancy)
24-28 wks // 32-36 wks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30-170 ng/mL // 60-280 ng/mL . . . . . . . . . . . . . . . 104-590 // 208-970 nmol/L
28-32 wks // 36-40 wks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40-220 ng/mL // 80-350 ng/mL . . . . . . . . . . . . . . . 140-760 // 280-1210 nmol/L
Ferritin, serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Male: 15-200 ng/mL . . . . . . . . . . . . . . . . . . . . . . . 15-200 µg/L
Female: 12-150 ng/mL . . . . . . . . . . . . . . . . . . . . . . 12-150 µg/L
Follicle-stimulating hormone, serum/plasma . . . . . . . . . . . . . . . Male: 4-25 mIU/mL . . . . . . . . . . . . . . . . . . . . . . . 4-25 U/L
Female: premenopause 4-30 mIU/mL . . . . . . . . . . 4-30 U/L
midcycle peak 10-90 mIU/mL . . . . . . . . . . . . . . . 10-90 U/L
postmenopause 40-250 mIU/mL . . . . . . . . . . . . 40-250 U/L
Gases, arterial blood (room air)
pH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.35-7.45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [H+] 36-44 nmol/L
PCO2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33-45 mm Hg . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.4-5.9 kPa
PO2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75-105 mm Hg . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.0-14.0 kPa
* Glucose, serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fasting: 70-110 mg/dL . . . . . . . . . . . . . . . . . . . . . 3.8-6.1 mmol/L
2-h postprandial: < 120 mg/dL . . . . . . . . . . . . . . < 6.6 mmol/L
Growth hormone - arginine stimulation . . . . . . . . . . . . . . . . . . . Fasting: < 5 ng/mL . . . . . . . . . . . . . . . . . . . . . . . . < 5 µg/L
provocative stimuli: > 7 ng/mL . . . . . . . . . . . . . . > 7 µg/L
Immunoglobulins, serum
IgA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76-390 mg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.76-3.90 g/L
IgE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0-380 IU/mL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0-380 kIU/L
IgG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 650-1500 mg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . 6.5-15 g/L
IgM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40-345 mg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.4-3.45 g/L
Iron . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50-170 µg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9-30 µmol/L
Lactate dehydrogenase, serum . . . . . . . . . . . . . . . . . . . . . . . . . . . 45-90 U/L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45-90 U/L
Luteinizing hormone, serum/plasma . . . . . . . . . . . . . . . . . . . . . . Male: 6-23 mIU/mL . . . . . . . . . . . . . . . . . . . . . . . 6-23 U/L
Female: follicular phase 5-30 mIU/mL . . . . . . . . . 5-30 U/L
midcycle 75-150 mIU/mL . . . . . . . . . . . . . . . . . . 75-150 U/L
postmenopause 30-200 mIU/mL . . . . . . . . . . . . 30-200 U/L
Osmolality, serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 275-295 mOsmol/kg . . . . . . . . . . . . . . . . . . . . . . . 275-295 mOsmol/kg
Parathyroid hormone, serum, N-terminal . . . . . . . . . . . . . . . . . . 230-630 pg/mL . . . . . . . . . . . . . . . . . . . . . . . . . . . 230-630 ng/L
* Phosphatase (alkaline), serum (p-NPP at 30EC) . . . . . . . . . . . . 20-70 U/L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20-70 U/L
* Phosphorus (inorganic), serum . . . . . . . . . . . . . . . . . . . . . . . . . . 3.0-4.5 mg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.0-1.5 mmol/L
Prolactin, serum (hPRL) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . < 20 ng/mL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . < 20 µg/L
* Proteins, serum
Total (recumbent) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.0-7.8 g/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60-78 g/L
Albumin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.5-5.5 g/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35-55 g/L
Globulin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.3-3.5 g/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23-35 g/L
Thyroid-stimulating hormone, serum or plasma . . . . . . . . . . . . . 0.5-5.0 µU/mL . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.5-5.0 mU/L
Thyroidal iodine (123 I) uptake . . . . . . . . . . . . . . . . . . . . . . . . . . . 8-30% of administered dose/24 h . . . . . . . . . . . . . . 0.08-0.30/24 h
Thyroxine (T 4 ), serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-12 µg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64-155 nmol/L
Triglycerides, serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35-160 mg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.4-1.81 mmol/L
Triiodothyronine (T 3 ), serum (RIA) . . . . . . . . . . . . . . . . . . . . . 115-190 ng/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.8-2.9 nmol/L
Triiodothyronine (T 3 ) resin uptake . . . . . . . . . . . . . . . . . . . . . . . 25-35% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.25-0.35
* Urea nitrogen, serum (BUN) . . . . . . . . . . . . . . . . . . . . . . . . . . . 7-18 mg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.2-3.0 mmol urea/L
* Uric acid, serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.0-8.2 mg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.18-0.48 mmol/L
21
USMLE Step 1 Laboratory Values (continued)
HEMATOLOGIC
Bleeding time (template) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-7 minutes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2-7 minutes
Erythrocyte count . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Male: 4.3-5.9 million/mm3 . . . . . . . . . . . . . . . . . . . 4.3-5.9 x 1012 /L
Female: 3.5-5.5 million/mm3 . . . . . . . . . . . . . . . . . 3.5-5.5 x 1012 /L
Erythrocyte sedimentation rate (Westergren) . . . . . . . . . . . . . . . Male: 0-15 mm/h . . . . . . . . . . . . . . . . . . . . . . . . . . 0-15 mm/h
Female: 0-20 mm/h . . . . . . . . . . . . . . . . . . . . . . . . . 0-20 mm/h
Hematocrit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Male: 41-53% . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.41-0.53
Female: 36-46% . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.36-0.46
Hemoglobin A1C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . < 6% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . < 0.06%
Hemoglobin, blood . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Male: 13.5-17.5 g/dL . . . . . . . . . . . . . . . . . . . . . . . 2.09-2.71 mmol/L
Female: 12.0-16.0 g/dL . . . . . . . . . . . . . . . . . . . . . . 1.86-2.48 mmol/L
Hemoglobin, plasma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-4 mg/dL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.16-0.62 mmol/L
Leukocyte count and differential
Leukocyte count . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4500-11,000/mm3 . . . . . . . . . . . . . . . . . . . . . . . . . . 4.5-11.0 x 109 /L
Segmented neutrophils . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54-62% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.54-0.62
Bands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-5% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.03-0.05
Eosinophils . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1-3% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.01-0.03
Basophils . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0-0.75% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0-0.0075
Lymphocytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25-33% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.25-0.33
Monocytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-7% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.03-0.07
Mean corpuscular hemoglobin . . . . . . . . . . . . . . . . . . . . . . . . . . 25.4-34.6 pg/cell . . . . . . . . . . . . . . . . . . . . . . . . . . 0.39-0.54 fmol/cell
Mean corpuscular hemoglobin concentration . . . . . . . . . . . . . . . 31-36% Hb/cell . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.81-5.58 mmol Hb/L
Mean corpuscular volume . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80-100 µm3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80-100 fl
Partial thromboplastin time (activated) . . . . . . . . . . . . . . . . . . . 25-40 seconds . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25-40 seconds
Platelet count . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150,000-400,000/mm3 . . . . . . . . . . . . . . . . . . . . . . 150-400 x 109 /L
Prothrombin time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11-15 seconds . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11-15 seconds
Reticulocyte count . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.5-1.5% of red cells . . . . . . . . . . . . . . . . . . . . . . . 0.005-0.015
Thrombin time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . < 2 seconds deviation from control . . . . . . . . . . . . <2 seconds deviation from control
Volume
Plasma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Male: 25-43 mL/kg . . . . . . . . . . . . . . . . . . . . . . . . . 0.025-0.043 L/kg
Female: 28-45 mL/kg . . . . . . . . . . . . . . . . . . . . . . . 0.028-0.045 L/kg
Red cell . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Male: 20-36 mL/kg . . . . . . . . . . . . . . . . . . . . . . . . 0.020-0.036 L/kg
Female: 19-31 mL/kg . . . . . . . . . . . . . . . . . . . . . . . 0.019-0.031 L/kg
SWEAT
Chloride . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0-35 mmol/L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0-35 mmol/L
URINE
Calcium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100-300 mg/24 h . . . . . . . . . . . . . . . . . . . . . . . . . . 2.5-7.5 mmol/24 h
Chloride . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Varies with intake . . . . . . . . . . . . . . . . . . . . . . . . . Varies with intake
Creatinine clearance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Male: 97-137 mL/min
Female: 88-128 mL/min
Estriol, total (in pregnancy)
30 wks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6-18 mg/24 h . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21-62 µmol/24 h
35 wks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9-28 mg/24 h . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31-97 µmol/24 h
40 wks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13-42 mg/24 h . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45-146 µmol/24 h
17-Hydroxycorticosteroids . . . . . . . . . . . . . . . . . . . . . . . . . . . . Male: 3.0-10.0 mg/24 h . . . . . . . . . . . . . . . . . . . . . 8.2-27.6 µmol/24 h
Female: 2.0-8.0 mg/24 h . . . . . . . . . . . . . . . . . . . . . 5.5-22.0 µmol/24 h
17-Ketosteroids, total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Male: 8-20 mg/24 h . . . . . . . . . . . . . . . . . . . . . . . . 28-70 µmol/24 h
Female: 6-15 mg/24 h . . . . . . . . . . . . . . . . . . . . . . . 21-52 µmol/24 h
Osmolality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50-1400 mOsmol/kg
Oxalate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8-40 µg/mL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90-445 µmol/L
Potassium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Varies with diet . . . . . . . . . . . . . . . . . . . . . . . . . . . Varies with diet
Proteins, total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . <150 mg/24 h . . . . . . . . . . . . . . . . . . . . . . . . . . . . <0.15 g/24 h
Sodium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Varies with diet . . . . . . . . . . . . . . . . . . . . . . . . . . . Varies with diet
Uric acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Varies with diet . . . . . . . . . . . . . . . . . . . . . . . . . . . Varies with diet
22
Answer Form for Step 1 Sample Questions
23
Sample Questions
1. A 74-year-old man with urinary frequency and ur- 4. A man pushes a piano across the floor. At the
gency has benign prostatic hypertrophy. He re- wrist, the force is transmitted from the carpal bones
fuses operative intervention but agrees to a trial of to the radius. At the elbow, the force is transmitted
finasteride therapy. During the trial, synthesis of from the ulna to the humerus. Which of the follow-
which of the following substances is most likely to ing structures transmits the force from the radius to
be inhibited? the ulna?
2. A 10-month-old girl cries when her mother tries to 5. A 50-year-old woman has had a painless mass in
put her in her grandmother’s arms. She happily the parotid gland for the past 8 months. A 2-cm,
allowed herself to be held when her grandmother discrete solid mass is found in the parotid gland on
visited 2 months ago. Which of the following best parotidectomy. Histologic examination shows a
explains this behavior? neoplastic lesion with uniform epithelial and
myoepithelial cells; these cells form acini, tubules,
(A) Development of problems with socialization and ducts supported by myxoid and chondroid
(B) Maltreatment by the grandmother stroma. Which of the following is the most likely
(C) Sensation of a poor relationship between the complication of this type of parotid lesion?
mother and the grandmother
(D) Separation anxiety disorder (A) Contralateral immune-mediated parotitis
(E) Stranger anxiety (B) Hematogenous metastases to lungs and
bone
(C) Ipsilateral submaxillary salivary gland neo-
3. A 30-year-old woman being treated for hyperten- plasm
sion has the sudden onset of fever and malaise. (D) Local recurrence
Temperature is 38.3 C (101 F) orally and blood pres- (E) Regional lymph node metastases
sure is normal. She has a malar rash, swelling and
tenderness of the wrists and knees, and a friction
rub at the left lower sternal border. Which of the 6. Enteric gram-negative bacteria are more resistant to
following drugs is the most likely cause of these penicillin G than gram-positive bacteria. Which of
findings? the following is most closely associated with this
difference?
(A) Captopril
(B) Hydralazine (A) Cytoplasmic membrane
(C) Minoxidil (B) Lipoprotein
(D) Nitroprusside (C) Outer membrane
(E) Propranolol (D) Peptidoglycan
(E) Teichoic acid
24
7. An inexpensive screening test for a disease is avail- 10. Platelet-derived growth factor binds to its receptor,
able through analysis of venous blood. The distri- activating cell growth. The receptor-growth factor
butions of blood concentrations for persons with complex uses which of the following mechanisms to
and without the disease are depicted in the graph. signal the cell to divide?
The disease is irreversible and fatal if not discov-
ered and treated early. What letter represents the (A) Activation of tyrosine kinase
most appropriate cutoff point between normal and (B) Binding of GTP to a G protein
abnormal? (C) Binding to DNA
(D) Increase in intracellular calcium concentra-
tion
(E) Opening of an ion channel
25
16. A 60-year-old man develops a tremor in his fingers.
The tremor is most pronounced when he reaches
for his coffee cup or points to an object. Which
component of the motor system is most likely to be
involved?
15. A 16-year-old boy has jaundice. Laboratory studies (A) Decreased insulin-like growth factor 1 con-
show an increase in both mean corpuscular hemo- centration
globin concentration and osmotic fragility of ery- (B) Increased alkaline phosphatase activity
throcytes. Liver enzyme activities are within the (C) Increased calcium concentration
reference range, and a direct antiglobulin test is (D) Increased phosphorus concentration
negative. Which of the following types of erythro- (E) Increased urea nitrogen (BUN) concentra-
cyte is most likely to be found on a peripheral blood tion
smear from this patient?
26
20. The unlabeled solid curve represents the loading 23. Flow cytometric data of T lymphocytes stained with
behavior of normal human hemoglobin at pH 7.35 as fluorescent antibody to CD4+ and CD8+ antigens
a function of oxygen concentration. Which curve from a healthy person are shown. The lymphocytes
best represents the most likely change following from which quadrant will respond most vigorously
addition of carbon dioxide? to immunization with hepatitis A virus vaccine?
27
26. Four drugs produce the same therapeutic effect by the same mechanism, but each has a unique toxicity. When used at a
maximally effective therapeutic dose, the drug with which of the following sets of characteristics is most likely to have the
highest incidence of toxicity?
27. A cardiac catheterization is done in a healthy person. 30. A 56-year-old man has progressive shortness of
The blood sample withdrawn from the catheter shows breath, a cough, and a low-grade fever. He began
60% oxygen saturation, and the pressure recording taking a drug for recurrent ventricular arrhythmias 5
shows oscillations from a maximum of 26 mm Hg to a months ago. Erythrocyte sedimentation rate is in-
minimum of 14 mm Hg. Where was the catheter tip creased. Pulmonary function tests show decreased
located? diffusing capacity. X-ray film of the chest shows
diffuse interstitial pneumonia. Which of the following
(A) Ductus arteriosus drugs is the most likely cause of these findings?
(B) Foramen ovale
(C) Left atrium (A) Amiodarone
(D) Pulmonary artery (B) Angiotensin-converting enzyme (ACE) in-
(E) Right atrium hibitor
(C) Atenolol
(D) Furosemide
28. A 12-year-old girl is admitted to the hospital because (E) Metronidazole
of marked shortness of breath, an erythematous rash, (F) Penicillin
and painful, swollen hip and knee joints. She is (G) Procainamide
agitated. X-ray film of the chest shows an enlarged (H) Propranolol
heart and changes consistent with pulmonary edema. (I) Tetracycline
Intractable congestive heart failure develops, and she (J) Verapamil
dies on the second hospital day. The child most likely
had a recent history of which of the following?
31. A 38-year-old woman has had the gradual develop-
(A) Cyanosis with chest pain ment of a goiter. Serum thyroxine (T4) and
(B) Jaundice triiodothyronine (T3) concentrations are in the refer-
(C) Meningitis ence range. Serum concentration of thyroid- stimulat-
(D) Pharyngitis ing hormone is slightly increased. Serum contains
(E) Skin infection antimicrosomalantibodies, but no thyroid-stimulating
hormone antibodies are detected. Which of the
following is the most likely diagnosis?
29. Which of the following drugs applied topically
produces mydriasis without producing cycloplegia? (A) Chronic autoimmune (Hashimoto’s)
thyroiditis
(A) Atropine (B) Graves’ disease
(B) Neostigmine (C) Primary atrophy of the thyroid gland
(C) Phentolamine (D) Riedel’s struma
(D) Phenylephrine (E) Subacute thyroiditis
(E) Pilocarpine
28
34. The control curve in the graph illustrates the relation-
ship between the initial velocity of a reaction and the
substrate concentration for any enzyme obeying
Michaelis-Menten kinetics. Which curve best repre-
sents the result that would be obtained by halving
32. A 73-year-old woman has episodes of abdominal pain the amount of enzyme?
and increasingly severe constipation. Test for occult
blood in stools is positive. The photo-micrograph (A) Curve 1
shows features of the resected colon. The most likely (B) Curve 2
diagnosis is (C) Curve 3
(D) Control curve
(A) adenocarcinoma
(B) diverticular disease
(C) polypoid adenoma 35. A malnourished 50-year-old man with alcoholism and
(D) villous adenoma severe dental caries has a 2-week history of malaise
(E) volvulus and right-sided chest pain. He is febrile and has a
cough productive of foul-smelling, purulent sputum.
33. A 7-year-old child has had a high fever and a sore X-ray film of the chest shows a fluid-filled cavity, 2
throat for 2 days. Examination shows pharyngeal cm in diameter, in the upper lobe of the right lung.
erythema, a swollen right tonsil with a creamy The most likely diagnosis is
exudate, and painful right submandibular
lymphadenopathy. Throat culture on blood agar (A) abscess
yields numerous small ß-hemolytic colonies that are (B) bronchiectasis
inhibited by bacitracin. Which of the following is the (C) pulmonary infarct
most likely causal organism? (D) squamous cell carcinoma
(E) tuberculosis
(A) Adenovirus
(B) Candida albicans 36. Three weeks after a renal transplant, a patient devel-
(C) Corynebacterium diphtheriae ops fever and leukopenia, followed by prostration
(D) Coxsackievirus and severe pulmonary and hepatic dysfunction.
(E) Epstein-Barr virus Which of the following is the most likely viral cause?
(F) Haemophilus influenzae
(G) Mycobacterium tuberculosis (A) Adenovirus type 12
(H) Mycoplasma pneumoniae (B) Coxsackievirus
(I) Rhinovirus (C) Cytomegalovirus
(J) Streptococcus pyogenes (group A) (D) Influenza virus
(E) Parvovirus B19
29
37. A couple requests blood typing of their 2-year-old child (father AB, Rh-negative; mother B, Rh-negative). Results of
hemagglutination assays of the child’s blood are as follows: (+ = hemagglutination; – = no hemagglutination)
38. A 29-year-old woman comes to the physician for a 40. A 24-year-old woman has a marked increase in the
consultation 1 month after her 7-year-old daughter size of her uterus between the 26th and 30th weeks of
was killed in an automobile accident. The patient is gestation. Ultrasonography shows a marked increase
upset and restless and wrings her hands frequently. in the amount of amniotic fluid; the fetus is normal
She cannot sleep at night, has lost her appetite, and size for gestational age. Which of the following is the
cries easily and frequently. She is preoccupied with most likely diagnosis?
thoughts of her daughter and sometimes thinks she
momentarily sees her daughter sitting in the living (A) Congenital heart disease
room. She says she wishes she had been hit by the (B) Duodenal atresia
car, too. She denies any thoughts of killing herself. (C) Erythroblastosis fetalis
Which of the following is the best explanation for (D) Horseshoe kidney
these findings? (E) Neural tube defect
30
42. A 12-year-old girl with sickle cell disease has pain in 45. Metabolism of 100 g of carbohydrate, 25 g of fat, and
her right arm. An x-ray film of her arm shows bony 20 g of protein yields approximately how many
lesions consistent with osteomyelitis. Which of the kilocalories?
following is the most likely causal organism?
(A) 300
(A) Clostridium septicum (B) 500
(B) Enterococcus faecalis (C) 700
(C) Listeria monocytogenes (D) 900
(D) Proteus mirabilis (E) 1100
(E) Pseudomonas aeruginosa
(F) Salmonella enteritidis
(G) Serratia marcescens 46. A male neonate has syndactyly of the index, middle,
and third fingers of his left hand. Which of the
following cellular processes is most likely to have
43. A 6-year-old girl has the sudden onset of swelling of failed during development?
her face, hands, legs, and feet 1 week after a viral
upper respiratory tract infection. She is afebrile and (A) Apoptosis
normotensive. Laboratory studies show: (B) Differentiation
(C) Fusion
Serum (D) Migration
Albumin 2.0 g/dL (E) Proliferation
Urea nitrogen (BUN) 6.0 mg/dL
Creatinine 0.6 mg/dL
Cholesterol 280 mg/dL
Urine protein 4+; 6.0 g/24 h 47. The intravenous administration of a substance results
in a decrease in mean arterial blood pressure. Labora-
Which of the following is the most likely diagnosis? tory studies show that the substance is inactivated
by peptidase. The substance is most likely to be
(A) Focal glomerulosclerosis
(B) Membranous glomerulonephritis (A) angiotensin II
(C) Membranoproliferative glomerulonephritis (B) bradykinin
(D) Minimal change disease (C) histamine
(E) Rapidly progressive glomerulonephritis (D) neuropeptide Y
(E) serotonin
31
49. Poisoning the Na + –K+ pump with digitalis causes 50. If the axillary artery is ligated proximally as it passes
which of the following changes in large axons? over the first rib, blood will be supplied to the distal
axillary artery through which of the following arter-
(A) Decreased intracellular Cl– concentration ies?
(B) Decreased intracellular K+ concentration
(C) Decreased intracellular Na + concentration (A) Brachial
(D) Immediate block in propagation of action (B) Internal thoracic
potentials (C) Subclavian
(E) Slow hyperpolarization of membrane poten- (D) Subscapular
tials (E) Vertebral
32
Sample Questions
51. A neonate develops meningitis. Streptococcus is 54. A healthy 19-year-old man receives a tetanus immuni-
isolated from the mother’s vagina. The organism zation booster prior to induction in the Marines. Six
agglutinates with antiserum directed against type B hours later, he has pain and massive swelling at the
surface carbohydrate. The virulence of this organism site of injection. The following day, the skin breaks
is related to a bacterial constituent that interferes with down, forming an ulcer at the site. Which of the
which of the following host phagocyte functions? following events plays a critical role in this reaction?
33
60. Gram-positive cocci in clusters are seen in purulent
fluid drained from a skin abscess. Rapid identification
of these organisms will be facilitated by evaluation of
the clumping of latex beads coated with
34
63. The following data are obtained during evaluation of an 18-year-old woman:
64. Warfarin is administered to a 56-year-old man follow- 66. A 20-year-old man is brought to the emergency
ing placement of a prosthetic cardiac valve. The department with frightening visual hallucinations. He
warfarin dosage is adjusted to maintain a prothrombin is confused, disoriented to time and place, and
time of 18 sec. Subsequently, trimethoprim- difficult to understand because of slurred speech.
sulfamethoxazole therapy is begun for recurring Which of the following is the most likely diagnosis?
urinary tract infections. In addition to monitoring
prothrombin time, what action should the physician (A) Brief reactive psychosis
take to maintain adequate anticoagulation? (B) Delirium
(C) Mania
(A) Begin therapy with vitamin K (D) Psychotic depression
(B) Increase the dosage of warfarin (E) Schizophrenia
(C) Make no alterations in the dosage of warfarin
(D) Reduce the dosage of warfarin
(E) Stop the warfarin and change to low-dose 67. A patient with an aneurysm of the aortic arch devel-
aspirin ops hoarseness. Paralysis of which of the following
muscles on the left side is most likely?
65. A genetic male has fully developed male sexual ducts (A) Anterior belly of the digastric
and recognizable uterine tubes. Which of the follow- (B) Cricothyroid
ing processes was most likely disturbed during the (C) Omohyoid
embryonic period? (D) Posterior belly of the digastric
(E) Posterior cricoarytenoid
(A) Production of estrogen by the embryonic
testes
(B) Production of müllerian-inhibitory substance 68. Large amounts of the artificial sweetener aspartame
by the embryonic testes should be avoided in children who have which of the
(C) Production of testosterone by the embryonic following metabolic disorders?
testes
(D) Response of the paramesonephric (müllerian) (A) Diabetes mellitus
ducts to estrogen (B) Hereditary fructose intolerance
(E) Response of the paramesonephric (müllerian) (C) Lactose intolerance
ducts to testosterone (D) Maple syrup urine disease
(E) Phenylketonuria
35
69. A 16-year-old girl is brought to the emergency depart- 72. Compared with normal persons, the dosage regimen
ment after attempting suicide by cutting her wrist. of a drug for a patient known to be a “rapid
The deepest part of the wound is between the ten- metabolizer” is modified most rationally by which of
dons of the flexor carpi radialis and the flexor the following loading and maintenance doses?
digitorum superficialis. She is most likely to have a
deficit in which of the following? Loading Maintenance
(A) Increased increased
(A) Adduction and abduction of the fingers (B) Increased normal
(C) Decreased normal
(B) Extension of the index finger (D) Normal decreased
(C) Flexion of the ring and little fingers (E) Normal increased
(D) Sensation over the base of the little finger
(E) Opposition of the thumb and other digits
73. An asymptomatic 50-year-old woman has hyperten-
70. A 34-year-old man has anorexia and nausea for 1 sion. Urinary excretion of catecholamines is in-
week followed by sudden darkening of his urine to a creased. A CT scan shows a suprarenal mass. Which
brownish color. Laboratory data are consistent with of the following is the most likely cause?
acute viral hepatitis. Screening serologic studies for
hepatitis A and B virus (HAV, HBV) infections show: (A) Benign neoplasm of the adrenal cortex
(B) Benign neoplasm of the adrenal medulla
IgM anti-HAV Ab negative (C) Malignant neoplasm of the adrenal cortex
HBV surface Ag positive (D) Malignant neoplasm of the adrenal medulla
IgM anti-HBV core Ab positive (E) Diffuse hyperplasia of the adrenal cortex
Anti-HBV surface Ab negative
(F) Diffuse hypoplasia of the adrenal medulla
Which of the following mechanisms best explains the
hepatic injury?
74. An otherwise healthy 55-year-old Asian-American
(A) Direct injury of hepatocyte membranes by man is given isoniazid and vitamin B6 (pyridoxine)
viral surface antigen after conversion of his PPD skin test. An x-ray film of
(B) Hepatocyte lysis by cytotoxic IgM antibody the chest shows no abnormalities. Four weeks later he
to viral core antigen develops abdominal pain and jaundice. Which of the
(C) Inhibition of hepatocyte DNA replication following is the most likely explanation?
(D) Inhibition of hepatocyte mRNA translation
(E) T lymphocyte-mediated lysis of infected (A) Hepatic tuberculosis
hepatic cells (B) Hepatitis B
(C) Isoniazid-induced hepatitis
71. An inherited metabolic disorder of carbohydrate (D) Pyridoxine-induced cholecystitis
metabolism is characterized by an abnormally in- (E) Tuberculous pancreatitis
creased concentration of hepatic glycogen with
normal structure and no detectable increase in serum
glucose concentration after oral administration of 75. A 45-year-old woman who is being treated for hyper-
fructose. These two observations suggest that the tension and hypercholesterolemia develops diffuse
disease is a result of the absence of which of the muscle pain and weakness. Serum creatine kinase
following enzymes? activity is increased. Which of the following drugs is
most likely to have caused this clinical picture?
(A) Fructokinase
Glucokinase (A) Captopril
(B)
Glucose 6-phosphatase (B) Hydrochlorothiazide
(C)
(D) Phosphoglucomutase (C) Lovastatin
(E) UDPG-glycogen transglucosylase (D) Nicotinic acid
(E) Propranolol
36
76. While smoking crack cocaine, a 16-year-old boy
develops substernal chest pain. An ECG is consistent
with anterior wall myocardial ischemia. The drug most
likely had which of the following effects on the heart?
78. A 37-year-old woman who is being treated for 81. An asymptomatic 26-year-old man has a scrotal mass.
promyelocytic leukemia develops septicemia followed When he is standing, the left scrotal sac is enlarged
by widespread ecchymoses and bleeding from mu- with a tubular, worm-like, freely movable, nontender
cous membranes and venipuncture sites. Dissemi- mass. The mass is not palpable when he is supine.
nated intravascular coagulopathy (DIC) is suspected. The most likely diagnosis is
Which of the following is the most specific laboratory
test to confirm the diagnosis? (A) cystocele
(B) ectasia of the spermatic duct
(A) D-dimer assay for fibrin split products (C) indirect inguinal hernia
(B) Partial thromboplastin time (D) spermatocele
(C) Plasma fibrinogen concentration (E) varicocele
(D) Platelet count
(E) Prothrombin time
82. During a prenatal visit, a 25-year-old woman who is
10 weeks’ pregnant comments that she feels too
79. A healthy 35-year-old woman has a cast removed nauseated and fatigued to be interested in sex, and
from her leg after 6 weeks of immobilization. Which of her husband wonders if they will ever be sexually
the following best characterizes her gastrocnemius active again. The most appropriate next step is to
muscle at this time? advise her that sexual interest often returns during
which of the following periods?
(A) Conversion to fast fibers
(B) Decrease in number of fibers (A) Second trimester
(C) Decrease in number of myofibrils (B) Third trimester
(D) Increase in mitochondrial content (C) First week postpartum
(E) Increase in number of satellite cells (D) First month postpartum
37
83. The following numbered codons relate to the partial sequence of an mRNA for a protein. Termination codons are UAG,
UGA and UAA; the initiation codon is AUG. The triplets are numbered as shown:
Insertion of uridine between the end of codon 135 and the beginning of 136 will result in a protein containing how many
amino acids?
(A) 134
(B) 135
(C) 136
(D) 137
(E) 138
84. Infection of macrophages with viruses (eg, dengue) 86. A 30-year-old woman with a 1-week history of severe
or bacterial pathogens (eg, Listeria monocytogenes) diarrhea feels dizzy when she stands up. Blood
that escape from the phagosome to the cytoplasm pressure (supine) is 112/76 mm Hg with a pulse of
results in the stimulation of which of the following 88/min; blood pressure (on standing) is 80/60 mm Hg
classes of lymphocytes? with a pulse of 120/min. In addition to controlling her
diarrhea, the most appropriate initial therapy is
Antigen-specific intravenous administration of
restricted MHC class T lymphocyte
(A) I CD4+ cytotoxic (A) desmopressin
(B) I CD8+ cytotoxic
(B) 5% dextrose in water
(C) I CD8+ helper
(D) II CD4+ helper (C) fresh frozen plasma
(E) II CD8+ cytotoxic (D) isotonic saline
(E) methoxamine
(F) verapamil
85. A 60-year-old man has a 10-day history of
nonproductive cough and dyspnea on exertion. In
addition to a normal left lung base, physical examina- 87. A 74-year-old man has colicky abdominal pain in the
tion of his chest in the area of the right lung base left lower quadrant, leukocytosis, and fever. He has
discloses: not had diarrhea or constipation. The most likely
diagnosis is
Breath sounds bronchial
Percussion note dull (A) carcinoma of the sigmoid colon
Tactile fremitus increased
(B) diverticulitis
Adventitious sounds crackles
(C) familial adenomatous polyposis
The most likely diagnosis is (D) ulcerative colitis
(E) villous adenoma of the upper rectum
(A) asthmatic bronchitis
(B) bullous emphysema
(C) chronic bronchitis 88. A 75-year-old man with a history of constipation and
(D) congestive heart failure episodic abdominal pain has diverticulosis. He is at
(E) lobar pneumonia increased risk for which of the following conditions?
(F) pleural effusion
(G) pleuritis (A) Angiodysplasia
(H) pneumothorax (B) Carcinoma of the colon
(I) pulmonary embolism (C) Gastrointestinal hemorrhage
(D) Granulomatous colitis
(E) Malabsorption
38
89. Which of the figures (A-E) best illustrates the relationship between blood flow and mean arterial pressure (MAP) in a
vascular bed that demonstrates autoregulation of blood flow?
90. A 24-year-old woman who breast feeds her infant 92. A 4-year-old girl has been unable to eat for 2 days
develops a warm, painful mass and erythema of the because of a gastrointestinal tract disorder. Which of
overlying skin in the upper outer quadrant of the the following is the major source of fuel being oxi-
right breast. The pain and redness resolve with dized by her skeletal muscles?
antibiotic therapy. Several months later, the same area
is firm and the overlying skin is dimpled. Which of (A) Muscle creatine phosphate
the following is the most likely cause of these find- (B) Muscle glycogen
ings? (C) Muscle triglycerides
(D) Serum fatty acids
(A) Breast abscess with scarring (E) Serum glucose
(B) Fibroadenoma
(C) Fibrocystic change
(D) Infiltrating mammary carcinoma 93. Which of the following is the best example of regres-
(E) Traumatic fat necrosis sion as a normal response to illness?
39
94. The parents of a 2-year-old boy are concerned be- 97. The intracellular domain of the insulin receptor has
cause he has been having frequent temper tantrums which of the following enzyme activities?
in public. The physician should recommend which of
the following? (A) Adenylyl cyclase
(B) Phosphodiesterase
(A) Distracting him by offering him a treat (C) Phospholipase C
(B) Ignoring the tantrums as much as possible (D) Phosphoprotein phosphatase
(C) Spanking him when the tantrums occur (E) Tyrosine kinase
(D) Threatening to leave him alone in the place
where the tantrums occur
98. Which of the following characteristics of amphet-
amines is most likely to be responsible for increasing
95. A 70-kg (154-lb) man on a fixed NaCl intake (200 blood pressure?
mmol/day) is given daily injections of a potent
mineralocorticoid hormone for 4 days. He has free (A) Indirect release of endogenous catechol-
access to water and consumes his usual caloric amines
intake. Excretion of NaCl is as follows: (B) Inhibition of catecholamine metabolism
(C) Metabolism to false neurochemical transmit-
Day NaCl (mmol) ters
(D) Potent a 1-adrenergic agonism
1 30 (E) Potent ß 2-adrenergic agonism
2 90
3 180
4 200
99. A 35-year-old man sustains a full-thickness burn over
Assuming that 1 L of isotonic saline contains 150 the dorsum of his forearm. A local flap of normal skin
mmol of NaCl and weighs 1 kg, how much will he and subcutaneous tissue is rotated into the defect.
weigh (in kg) at the end of day 4? This skin will survive because of small, horizontally
oriented vessels in the
(A) 66
(B) 68 (A) basal layer
(C) 70 (B) deep dermis
(D) 72 (C) stratum corneum
(E) 74 (D) stratum lucidum
(E) subcutaneous fat
40
Sample Questions
101. Following infection with measles virus, a 6-year-old 104. A 40-year-old man with a 20-year history of alcohol
boy produces antibodies to all eight viral proteins. abuse is brought to the hospital by his friends be-
The following year he is again exposed to measles cause he was difficult to rouse. He ate a large meal
virus. Antibodies to which viral protein are most several hours ago. He is emaciated and lethargic.
likely to be protective? Examination shows severely restricted horizontal eye
movements and ataxia of both upper limbs. The most
(A) Hemagglutinin likely cause of these findings is a deficiency of which
(B) Matrix of the following nutrients?
(C) Nonstructural
(D) Nucleocapsid (A) Folate
(E) Polymerase (B) Vitamin A
(C) Vitamin B1 (thiamine)
(D) Vitamin B6 (pyridoxine)
102. Which of the following best explains why neonates (E) Vitamin B12 (cyanocobalamin)
with sickle cell disease do not have symptoms at
birth?
105. Several contiguous cells are labeled with a fluores-
(A) The concentration of hemoglobin S is too cent dye that cannot cross cell membranes. One cell
low is experimentally bleached with light that destroys the
(B) Maternal antibodies coat the neonatal cells dye, but the cell soon recovers dye fluorescence.
and inhibit the sickling phenomenon This recovery is best explained by the presence of
(C) Maternal erythrocytes protect neonatal which of the following structures between the
erythrocytes from sickling bleached cell and its fluorescent neighbors?
(D) Neonatal erythrocytes are exposed to a
higher concentration of oxygen than adult (A) A basal lamina
erythrocytes (B) Desmosomes (maculae adherentes)
(E) The spleen of the neonate can effectively (C) Gap junctions
filter out the sickled cells (D) Glycosaminoglycans
(E) Tight junctions (zonulae occludentes)
41
109. The figure shows the base pairing of a short duplex
DNA molecule; circles represent the phosphorus
molecules, and the letters represent each of the four
common bases present in DNA. The type II restric-
tion endonuclease Bc/I will cut symmetrically within
the six base-pair palindrome of dyad symmetry that
occurs within which of the following portions of the
DNA molecule?
42
112. A mother brings her 2-year-old daughter to the 116. A 48-year-old woman has loss of pain and tempera-
emergency department after finding her bottle of iron ture sensation in the left upper and lower limbs.
pills spilled on the floor and noticing that her daugh- Which of the following labeled areas in the medulla is
ter’s mouth was discolored. The child’s plasma iron the most likely site of the causal lesion?
concentration is 400 µg/dL. Which of the following
agents is most appropriate for chelation therapy?
(A) Acetylcysteine
(B) Calcium disodium edetate (EDTA)
(C) Deferoxamine
(D) Dimercaprol
(E) Penicillamine
(A) Erythropoietin
(B) Ferrous sulfate
(C) Folate
(D) Vitamin B6 (pyridoxine)
(E) Vitamin B12 (cyanocobalamin) 117. Failure of an endonuclease to recognize the sequence
AAUAAA in the 3' end of heterogeneous nuclear
RNA will cause a defect in which of the following
114. A 58-year-old man with chronic congestive heart processes involving mRNA?
failure requires ongoing hydrochlorothiazide therapy.
His monthly serum chemistry profile shows persistent (A) Capping
hypokalemia. The most appropriate next step is to (B) Hybridization
add which of the following diuretics to the regimen? (C) Polyadenylation
(D) Splicing
(A) Acetazolamide (E) Transport
(B) Amiloride
(C) Furosemide
(D) Mannitol 118. A 16-year-old girl is incoherent and has a fever,
(E) Metolazone severe lower abdominal pain, and a foul-smelling
cervicovaginal discharge. A self-induced abortion is
suspected. Which of the following methods should
115. Moderate alcohol consumption may protect against be used to collect a sample of the cervical discharge
coronary artery disease by which of the following for bacterial culture?
mechanisms?
(A) Inoculating the specimen on mammalian epi-
(A) Decreasing serum concentration of LDLs thelial cells
(B) Decreasing serum concentration of triglycer- (B) Placing a swab in transport medium at room
ides temperature
(C) Increasing contractile proteins in coronary (C) Taking samples of the discharge with a sy-
arteries ringe and transferring them directly into an
(D) Increasing serum concentration of HDLs anaerobic transport medium
(E) Increasing thromboxane B2 release from (D) Using a calibrated inoculating loop to enable
platelets direct enumeration of the bacteria in the
specimen
43
119. Patients X and Y both have respirations of 12/min and 122. A 38-year-old woman has congestive heart failure,
tidal volumes of 500 mL. However, patient X has an premature ventricular contractions, and repeated
arterial PCO2 of 35 mm Hg, while patient Y has an episodes of ventricular tachycardia. Her blood pres-
arterial PCO2 of 45 mm Hg. The difference in PCO2 sure is normal and there are no murmurs. Her heart is
between these patients is best explained by a differ- markedly enlarged. Coronary angiography shows no
ence in which of the following? abnormalities. Which of the following is the most
likely diagnosis?
(A) Cardiac output
(B) Dead space ventilation (A) Acute rheumatic fever
(C) Forced expiratory volume in 1 sec (FEV1) (B) Congenital fibroelastosis
(D) Functional residual capacity (C) Constrictive pericarditis
(E) Lung compliance (D) Myocardial infarction
(E) Primary cardiomyopathy
(A) aldosterone deficiency 124. A 52-year-old man with chronic obstructive pulmo-
(B) anxiety reaction with hyperventilation nary disease who has been taking theophylline for 14
(C) diabetes mellitus with ketoacidosis years now requires treatment for hypertension, peptic
(D) ingestion of anabolic steroids
ulcer, and tuberculosis. After 2 weeks of therapy, he
(E) surreptitious use of diuretics has a toxic plasma theophylline concentration. The
drug most likely to have caused the theophylline
121. A 30-year-old woman whose mother and grandmother toxicity is
have died from carcinoma of the breast refuses to
have mammography. She says she knows she is at (A) cimetidine
risk but says, “I hate having my breasts (B) hydrochlorothiazide
squashed–it’s uncomfortable.” Her physician would (C) prazosin
like her to have annual mammograms. Which of the (D) rifampin
following is most likely to influence her to agree to
have mammograms? 125. A 38-year-old woman with hypertension and
hypokalemia is suspected of having hyperaldo-
(A) Exaggerate her risk for breast cancer steronism. In addition to serum aldosterone measure-
(B) Insist that she obtain counseling regarding ment, initial evaluation of this patient should include
unresolved grief measurement of which of the following?
(C) Offer analgesia prior to mammography
(D) Show her photographs of the results of un- (A) Plasma ACTH
treated cancer (B) Plasma cortisol
(E) Tell her that the therapeutic relationship will (C) Plasma prolactin
be terminated unless she has annual mam- (D) Plasma renin
mograms (E) Urinary sodium
44
126. A 17-year-old girl sustains a contaminated deep 130. A 23-year-old woman has a progressive increase in
puncture wound while helping repair a barn. Her im- serum human chorionic gonadotropin (hCG) concen-
munization record indicates that her last tetanus trations over an 8-week period. A hydatidiform mole
immunization was 12 years ago. In addition to wound is removed, but the hCG concentration continues to
care, which of the following is the most appropriate increase. The most likely diagnosis is
management?
(A) adrenal adenoma
(A) Tetanus antitoxin (B) choriocarcinoma
(B) Tetanus toxoid (C) ectopic pregnancy
(C) Tetanus antitoxin plus toxoid (D) pituitary insufficiency
(D) Tetanus toxoid plus adjuvant (E) a second noninvasive mole
(E) No intervention
129. Chronic ingestion of ethanol decreases the rate of 133. A patient with the classical phenotypic features of
gluconeogenesis because of decreased formation of Down’s syndrome has 46 chromosomes on each of
100 metaphase karyotypes. Which of the following
(A) ATP and 3-phosphoglycerate from best explains this finding?
1,3-bisphosphoglycerate
(B) fructose 1,6-bisphosphate from fructose (A) Deletion
6-phosphate (B) Mosaicism
(C) glyceraldehyde 3-phosphate from fructose (C) Somatic mutation
1,6-bisphosphate (D) Translocation
(D) pyruvate from lactate (E) Undetected trisomy
(E) pyruvate from phosphoenolpyruvate
45
134. Breast carcinomas often cause the skin of the breast
to become puffy and pitted, resembling orange peel.
The pits most likely correspond with which of the
following?
46
140. An 8-year-old boy needs to be coaxed to go to 143. Investigators are studying the use of a new labora-
school and, while there, often complains of severe tory test to identify patients with a particular disease.
headaches or stomach pain. His mother frequently The table below summarizes the results of initial
has to take him home because of his symptoms. At research involving 200 subjects.
night, he tries to sleep with his parents. When they
insist that he sleep in his own room, he says there are
monsters in his closet. Which of the following best
explains this behavior?
(A) Axillary
142. A 50-year-old man is awakened in the middle of the (B) Intercostobrachial
night with acute pain and tenderness of the right (C) Right phrenic
knee. He has a low-grade fever. His knee is hot, red, (D) Right sympathetic chain
tender, and swollen. Analysis of the fluid from the (E) Right vagus
right knee shows:
Leukocytes 70,000/mm3 with 75% 145. After fasting, a patient has no gastric acid secretion
neutrophils when chewing and no receptive relaxation of the
Crystal analysis negatively birefringent proximal stomach when swallowing. Which of the
Gram’s stain negative following best explains these findings?
47
148. A 3-year-old boy with mental retardation has
hepatosplenomegaly. Analysis of tissue obtained on
biopsy of the liver shows unusually large amounts of
glucocerebroside. Which of the following enzymes is
most likely to be deficient?
48
Answer Key for Step 1 Sample Questions
49